Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, 90220 Oulu, Finland.
Cells. 2019 Jun 15;8(6):598. doi: 10.3390/cells8060598.
The ubiquitin and hypoxia-inducible factor (HIF) pathways are cellular processes involved in the regulation of a variety of cellular functions. Enzymes called ubiquitin E3 ligases perform protein ubiquitylation. The action of these enzymes can be counteracted by another group of enzymes called deubiquitinases (DUBs), which remove ubiquitin from target proteins. The balanced action of these enzymes allows cells to adapt their protein content to a variety of cellular and environmental stress factors, including hypoxia. While hypoxia appears to be a powerful regulator of the ubiquitylation process, much less is known about the impact of DUBs on the HIF system and hypoxia-regulated DUBs. Moreover, hypoxia and DUBs play crucial roles in many diseases, such as cancer. Hence, DUBs are considered to be promising targets for cancer cell-specific treatment. Here, we review the current knowledge about the role DUBs play in the control of HIFs, the regulation of DUBs by hypoxia, and their implication in cancer progression.
泛素和缺氧诱导因子 (HIF) 途径是参与调节多种细胞功能的细胞过程。称为泛素 E3 连接酶的酶执行蛋白质泛素化。这些酶的作用可以被另一组称为去泛素化酶 (DUBs) 的酶抵消,这些酶从靶蛋白中去除泛素。这些酶的平衡作用使细胞能够适应各种细胞和环境应激因素,包括缺氧。虽然缺氧似乎是泛素化过程的强大调节剂,但关于 DUBs 对 HIF 系统和缺氧调节的 DUBs 的影响知之甚少。此外,缺氧和 DUBs 在许多疾病中发挥着至关重要的作用,例如癌症。因此,DUB 被认为是癌症细胞特异性治疗的有前途的靶点。在这里,我们回顾了 DUB 在控制 HIF 中的作用、缺氧对 DUB 的调节以及它们在癌症进展中的作用的最新知识。